“…Intraluminal brachytherapy (radiation delivered through the lumens of the bile ducts) may provide this option, providing access and additional dose delivery to the tumor while sparing the surrounding normal tissues [3,7,8,. EBRT usually precedes brachytherapy [8,15,16,19,20,[22][23][24]29,30,32,34,36,[39][40][41]43] to decrease tumor bulk before implantation so that residual disease is encompassed by the limited range of the intraluminal radiation. At some institutions, implantation has preceded EBRT [3,[10][11][12][13][14][16][17][18][19]33,[37][38].…”